Literature DB >> 9508112

Outcome after microdiscectomy: results of a prospective single institutional study.

M R Quigley1, J Bost, J C Maroon, A Elrifai, M Panahandeh.   

Abstract

BACKGROUND: Although lumbar microdiscectomy is one of the most frequently performed spinal procedures, little consensus exists in the literature regarding results. Whereas retrospective reports boast success rates as high as 98%, prospective studies are less sanguine with statistics in the 73-77% range.
METHODS: Prospective single-institution outcome study of all patients undergoing virgin unilateral single-level microdiscectomies by study surgeons November 1990 to March 1992. Outcome determined by patient-reported responses to mail questionnaire or phone interview by a disinterested party.
RESULTS: There were 374 patients operated on, average age 42.4 years with mean length of symptoms 9.4 months, and 31.5% were Workman's Compensation cases. Total complication rate was less than 4%, and follow-up was accomplished for 86% of the patients. Overall success rate was 74% using a strict combination of patient-reported pain relief, work status not affected, absence of narcotic use, and satisfaction with the procedure. Using a multivariate logistic regression analysis, only Workman's Compensation claim and length of symptoms (>6 months) were related to success, with a positive outcome in 86% of non-Compensation patients with brief symptoms contrasting with 29% in Compensation cases of greater than 6 months duration.
CONCLUSIONS: A prospective analysis of the frequency of success after microdiscectomy yields results lower than anticipated based on retrospective studies and finds success related to the non-anatomic factors of length of symptoms and Workman's Compensation claims.

Entities:  

Mesh:

Year:  1998        PMID: 9508112     DOI: 10.1016/s0090-3019(97)00448-5

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  8 in total

1.  Full endoscopic treatment of dural tears in lumbar spine surgery.

Authors:  Joachim M Oertel; Benedikt W Burkhardt
Journal:  Eur Spine J       Date:  2017-05-20       Impact factor: 3.134

2.  Recurrence of radicular pain or back pain after nonsurgical treatment of symptomatic lumbar disk herniation.

Authors:  Pradeep Suri; James Rainville; David J Hunter; Ling Li; Jeffrey N Katz
Journal:  Arch Phys Med Rehabil       Date:  2012-04       Impact factor: 3.966

Review 3.  Incidence of Low Back Pain After Lumbar Discectomy for Herniated Disc and Its Effect on Patient-reported Outcomes.

Authors:  Scott L Parker; Stephen K Mendenhall; Saniya S Godil; Priya Sivasubramanian; Kevin Cahill; John Ziewacz; Matthew J McGirt
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

4.  What is different about workers' compensation patients? Socioeconomic predictors of baseline disability status among patients with lumbar radiculopathy.

Authors:  Steven J Atlas; Tor D Tosteson; Brett Hanscom; Emily A Blood; Glenn S Pransky; William A Abdu; Gunnar B Andersson; James N Weinstein
Journal:  Spine (Phila Pa 1976)       Date:  2007-08-15       Impact factor: 3.468

5.  Dorsal column stimulator applications.

Authors:  Claudio Yampolsky; Santiago Hem; Damián Bendersky
Journal:  Surg Neurol Int       Date:  2012-10-31

6.  Timing of Surgery in Tubular Microdiscectomy for Lumbar Disc Herniation and Its Effect on Functional Impairment Outcomes.

Authors:  Alessandro Siccoli; Marlies P de Wispelaere; Marc L Schröder; Victor E Staartjes
Journal:  Neurospine       Date:  2020-03-31

Review 7.  Transforaminal endoscopic surgery for symptomatic lumbar disc herniations: a systematic review of the literature.

Authors:  Jorm Nellensteijn; Raymond Ostelo; Ronald Bartels; Wilco Peul; Barend van Royen; Maurits van Tulder
Journal:  Eur Spine J       Date:  2009-09-15       Impact factor: 3.134

Review 8.  The timing of surgery in lumbar disc prolapse: A systematic review.

Authors:  Ashutosh B Sabnis; Ashish D Diwan
Journal:  Indian J Orthop       Date:  2014-03       Impact factor: 1.251

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.